John Curnow PhD

John obtained a PhD in Immunochemistry from the University of Southampton where his research examined the activities of bispecific antibodies for the immunotherapy of cancer, many years before these molecules entered clinical trials. His first post-doctoral position was in Marseille, where he studied the mechanisms that regulate T cell tolerance. A move to Oxford followed where he researched the role of T cells in myasthenia gravis. His interest in translational immunology continued when he was appointed lecturer at the University of Birmingham. His research was focused for many years on the regulation of immune responses in the eye and how these are altered in patients with uveitis. Over the past few years his research group have shifted to studies of multiple sclerosis, examining the early immunological events and how they can be used for both prognosis of disease progression and the development of novel therapeutic pathways. Dr Curnow established the MSc in Immunology and Immunotherapy, and is the current programme director.